Therapeutic development towards T follicular helper cells as a molecular target in myasthenia gravis disease
Source: Journal of Neuroimmunology
Data-driven explainable machine learning for personalized risk classification of myasthenic crisis
Source: International Journal of Medical Informatics
Aging and infectious diseases in myasthenia gravis
Source: Journal of the Neurological Sciences
Characteristics and healthcare utilization of patients with myasthenia gravis exacerbation
Source: Journal of the Neurological Sciences
Medical costs of treating myasthenia gravis in patients who need intravenous immunoglobulin (IVIg) – a register-based study
Source: Journal of Neurology
For Patient Families
To support patients and caregivers, Elsevier Health is making the latest research on these rare disorders available upon request at no cost.
Learn More
Note:
User acknowledges that these materials are provided for use at no charge as part of Elsevier’s efforts to support healthcare providers and patients. The information contained within the website is intended as a supplement to, and not a substitute for, the knowledge, expertise, skill and judgment of healthcare professionals involved in patient care. The content within this page may not be re-used, modified or re-distributed without prior written permission.
Cookies are used by this site. To decline or learn more, visit our cookie notice.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
